InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human ...
Urinary tract infection, or more commonly known as UTI, is far more common than you think. In the US, there are approximately 8.1 million visits made to doctors each year by patients experiencing ...